FDA approves Cubist drug to treat acute skin infections

June 21, 2014 3:14 AM

20 0

June 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it approved a new drug to treat acute bacterial skin infections made by Cubist Pharmaceuticals Inc.

The drug, Sivextro, is designed to treat serious acute bacterial skin and skin structure infections, or ABSSSI. These are infections that involve deep tissue or are associated with an underlying disease such as diabetes.

Also read: FDA approves BioMarin rare metabolic disorder drug, shares rise

Read more

To category page